DE69233116D1 - Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin - Google Patents

Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin

Info

Publication number
DE69233116D1
DE69233116D1 DE69233116T DE69233116T DE69233116D1 DE 69233116 D1 DE69233116 D1 DE 69233116D1 DE 69233116 T DE69233116 T DE 69233116T DE 69233116 T DE69233116 T DE 69233116T DE 69233116 D1 DE69233116 D1 DE 69233116D1
Authority
DE
Germany
Prior art keywords
suppression
aspirin
thrombox
mirror
percutaneous administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233116T
Other languages
English (en)
Other versions
DE69233116T2 (de
Inventor
Rudolph M Keimowitz
Desmond J Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keimowitz Rudolph M D
Vanderbilt University
Original Assignee
Keimowitz Rudolph M D
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keimowitz Rudolph M D, Vanderbilt University filed Critical Keimowitz Rudolph M D
Application granted granted Critical
Publication of DE69233116D1 publication Critical patent/DE69233116D1/de
Publication of DE69233116T2 publication Critical patent/DE69233116T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69233116T 1991-04-03 1992-04-02 Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin Expired - Fee Related DE69233116T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68019591A 1991-04-03 1991-04-03
US680195 1991-04-03
PCT/US1992/002576 WO1992020343A1 (en) 1991-04-03 1992-04-02 Suppression of thromboxane levels by percutaneous administration of aspirin

Publications (2)

Publication Number Publication Date
DE69233116D1 true DE69233116D1 (de) 2003-08-07
DE69233116T2 DE69233116T2 (de) 2004-08-26

Family

ID=24730117

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69233116T Expired - Fee Related DE69233116T2 (de) 1991-04-03 1992-04-02 Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin

Country Status (12)

Country Link
EP (1) EP0578780B1 (de)
JP (1) JPH06510984A (de)
KR (1) KR100247441B1 (de)
AT (1) ATE244011T1 (de)
AU (1) AU668352B2 (de)
CA (1) CA2107587C (de)
DE (1) DE69233116T2 (de)
DK (1) DK0578780T3 (de)
FI (1) FI934324A0 (de)
NO (1) NO306536B1 (de)
WO (1) WO1992020343A1 (de)
ZA (1) ZA922464B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921157A2 (en) 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
DE19616539A1 (de) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000351729A (ja) * 1999-06-08 2000-12-19 Shionogi & Co Ltd トロンボキサンa2受容体拮抗剤の経皮吸収製剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AU2002250756A1 (en) * 2001-04-19 2002-11-05 Universite De Montreal A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2295753A1 (fr) * 1974-12-23 1976-07-23 Despin Jean Composition a base d'acide acetyl-salicylique a usage topique
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
DE3583698D1 (de) * 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
AU668352B2 (en) 1996-05-02
KR100247441B1 (ko) 2000-04-01
FI934324A0 (fi) 1993-10-01
NO933529D0 (no) 1993-10-01
DE69233116T2 (de) 2004-08-26
ZA922464B (en) 1992-12-30
DK0578780T3 (da) 2003-08-18
CA2107587A1 (en) 1992-10-04
ATE244011T1 (de) 2003-07-15
NO933529L (no) 1993-11-29
JPH06510984A (ja) 1994-12-08
CA2107587C (en) 2004-11-23
EP0578780A1 (de) 1994-01-19
WO1992020343A1 (en) 1992-11-26
AU2014292A (en) 1992-12-30
EP0578780B1 (de) 2003-07-02
NO306536B1 (no) 1999-11-22

Similar Documents

Publication Publication Date Title
HUT65278A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino-benzazepine derivatives and pharmaceutical preparations containing them
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
CS195285A3 (en) Pyridazine derivatives substituted by cyclic amines and process forpreparing thereof
IT1179635B (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
HUT65192A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino benzazepine derivatives and pharmaceutical preparations containing
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
IL109144A (en) Glycoprotein IIB/IIIA inhibiting 4-pyridylamino heterocyclic derivatives process for their preparation and pharmaceutical compositions containing them
IT8720698A0 (it) Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.
UA40633C2 (uk) Фармацевтичний емульсійний склад, спосіб його одержання і спосіб зниження в короткий термін тиску крові
HU895286D0 (en) Process for the preparation of steroid 5alfa-reductase inhibiting compounds and pharmaceutical compositions containing such compounds
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
DE69233116D1 (de) Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin
NO177663C (no) Fremgangsmåte til fremstilling av farmasöytisk preparat med nitroglyserin til perkutan administrering
ES2181849T3 (es) Procedimiento para minimizar la perdida osea.
FI890257A (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
JPS5785370A (en) Antiallergic imidodisulfamides, manufacture and medicinal composition containing same
NO952611L (no) Derivater av benzoylekgonin, ekgonin og ekgonidin som medisiner
HUT48119A (en) Process for producing pharmaceutical compositions against addiction to nicotine and comprising 2-pyrimidinyl-1-piperazine derivatives
DK0443957T3 (da) Hidtil ukendte steroid-forbindelser med en spirogruppe i position 17, en fremgangsmåde og mellemprodukter til fremstilling deraf, deres anvendelse som lægemiddel og farmaceutiske præparater med indhold deraf
ATE260672T1 (de) Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung
DK89289A (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee